Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use INFASURF ® safely and effectively. See full prescribing information for INFASURF. INFASURF ® (calfactant) intratracheal suspension Initial U.S. Approval: 1998
Medication labelWhy this: Advisory · dailymed-prescription
INFASURF is indicated: to reduce the risk of respiratory distress syndrome (RDS) in preterm neonates <29 weeks of gestational age at risk for RDS. for the rescue treatment of RDS in preterm neonates ≤72 hours of age with RDS who require endotracheal intubation.
- generic_name
- calfactant
- product_names
- calfactant
- ndc
- 61938-456, 61938-456-03, 61938-456-06
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en